ARTICLE | Company News
Stem Cell Therapy deal
August 13, 2007 7:00 AM UTC
SCII acquired exclusive worldwide rights to anti-rejection umbilical cord blood stem cell technology from inventors Calvin Cao and Lixian Jiang. Cao is SCII's CEO and Jiang is COO and Patent Trademark...